21.33% Less Soleno Therapeutics Inc (NASDAQ:SLNO) Shorted Shares

Change of 21.33% for Soleno Therapeutics Inc (NASDAQ:SLNO)’s shorted shares was recorded. In March was published SLNO’s total 87,800 shorted shares by FINRA. That’s 21.33% down from 111,600 shares. Soleno Therapeutics Inc (NASDAQ:SLNO) has 23,500 shares average volume. It’ll cost 4 days for SLNO to recover its previous position. 1.19% is Soleno Therapeutics Inc float short.

SLNO is hitting $1.59 during the last trading session, after increased 7.43%.Currently Soleno Therapeutics, Inc. is uptrending after 17.42% change in last March 3, 2018. SLNO has 8,545 shares volume. SLNO outperformed by 17.42% the S&P500.

Soleno Therapeutics, Inc. focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.The firm is valued at $50.49 million. The companyÂ’s lead candidate, diazoxide choline controlled-release , a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is entering into Phase II/III clinical development.Last it reported negative earnings. It also markets medical devices, including the CoSense End-Tidal Carbon Monoxide (ETCO) monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns; and NeoPip T-piece resuscitator and related consumables, which deliver consistent pre-set inspiratory pressure and positive end-expiratory pressures, as well as temperature probes, scales, surgical tables, and patient surfaces.

For more Soleno Therapeutics, Inc. (NASDAQ:SLNO) news published recently go to: Globenewswire.com, Globenewswire.com, Seekingalpha.com, Streetinsider.com or Seekingalpha.com. The titles are as follows: “Soleno Therapeutics Announces Expansion of Ongoing Phase III Trial of DCCR in Prader-Willi Syndrome to Include Younger Patients – GlobeNewswire” published on September 06, 2018, “Soleno Therapeutics Announces Issuance of New U.S. Patent for DCCR Covering Treatment of Low Lean Body Mass in Prader-Willi Syndrome – GlobeNewswire” on September 04, 2018, “MYnd Analytics leads healthcare gainers; Synergy Pharmaceuticals tops losers – Seeking Alpha” with a publish date: October 26, 2018, “Form 424B1 Navios Maritime Containe – StreetInsider.com” and the last “Soleno up 16% premarket on move away from Capnia – Seeking Alpha” with publication date: December 08, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.